STOMP: Small cell lung cancer trial of olaparib (AZD2281) as maintenance programme - a randomised, double blind, multicentre NCRN phase II trial

被引：0
|
作者：
Woll, P. J. [1 ]
Jarrett, H. [2 ]
Billingham, L. [2 ]
机构：
[1] Univ Sheffield, Weston Pk Hosp, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Birmingham, CRUK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
来源：
LUNG CANCER | 2011年 / 71卷
关键词：
D O I：
10.1016/S0169-5002(11)70121-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [21] Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
    Sophie Postel-Vinay
    Juan Coves
    Matthieu Texier
    Mihaela Aldea
    Anas Gazzah
    Manuel Dómine
    David Planchard
    Ramon De Las Peñas
    Ma Angeles Sala Gonzalez
    Santiago Viteri
    Javier Perez
    Ana Laura Ortega
    Teresa Moran
    Carlos Camps
    Ana Lopez-Martin
    Mariano Provencio
    Jean-Charles Soria
    Benjamin Besse
    Bartomeu Massuti
    Rafael Rosell
    British Journal of Cancer, 2024, 130 : 417 - 424
  • [22] Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer
    Park, Sehhoon
    Kim, Yu Jung
    Min, Young Joo
    Mortimer, Peter G. S.
    Kim, Hee-Jung
    Smith, Simon A.
    Dean, Emma
    Jung, Hyun Ae
    Sun, Jong-Mu
    Park, Woong-Yang
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Lee, Se-Hoon
    Park, Keunchil
    CANCER, 2024, 130 (04) : 541 - 552
  • [23] Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
    Postel-Vinay, Sophie
    Coves, Juan
    Texier, Matthieu
    Aldea, Mihaela
    Gazzah, Anas
    Domine, Manuel
    Planchard, David
    De Las Penas, Ramon
    Gonzalez, Ma Angeles Sala
    Viteri, Santiago
    Perez, Javier
    Ortega, Ana Laura
    Moran, Teresa
    Camps, Carlos
    Lopez-Martin, Ana
    Provencio, Mariano
    Soria, Jean-Charles
    Besse, Benjamin
    Massuti, Bartomeu
    Rosell, Rafael
    BRITISH JOURNAL OF CANCER, 2023, 130 (03) : 511 - 511
  • [24] Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial
    Ledermann, J. A.
    Perren, T. J.
    Raja, F. A.
    Embleton, A.
    Rustin, G. J. S.
    Jayson, G.
    Kaye, S. B.
    Swart, A. M.
    Vaughan, M.
    Hirte, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S5 - S6
  • [25] Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
    Al-Chalabi, Ammar
    Shaw, Pamela
    Leigh, P. Nigel
    van den Berg, Leonard
    Hardiman, Orla
    Ludolph, Albert
    Aho, Valtteri V.
    Sarapohja, Toni
    Kuoppamaki, Mikko
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (10): : 1165 - 1170
  • [26] A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC)
    Lee Siow-Ming
    Woll, Penella J.
    Rudd, Robin M.
    Gower, Nicole H.
    Ottensmeier, Christian H.
    Ali, Kulsam
    Spiro, Stephen G.
    Hackshaw, Allan
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S359 - S359
  • [27] Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy
    Dowlati, Afshin
    Subbiah, Shanmuga
    Cooney, Matthew
    Rutherford, Kimberly
    Mekhail, Tarek
    Fu, Pingfu
    Chapman, Robert
    Ness, Anne
    Cortas, Tania
    Saltzman, Joel
    Levitan, Nathan
    Warren, Gregory
    LUNG CANCER, 2007, 56 (03) : 377 - 381
  • [28] Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer
    Lee, Siow Ming
    James, Lindsay
    Buchler, Tomas
    Snee, Mike
    Ellis, Paul
    Hackshaw, Allan
    LUNG CANCER, 2008, 59 (03) : 364 - 368
  • [29] Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer
    Sharma, Neelesh
    Pennell, Nathan
    Nickolich, Myles
    Halmos, Balazs
    Ma, Patrick
    Mekhail, Tarek
    Fu, Pingfu
    Dowlati, Afshin
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 362 - 368
  • [30] Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer
    Neelesh Sharma
    Nathan Pennell
    Myles Nickolich
    Balazs Halmos
    Patrick Ma
    Tarek Mekhail
    Pingfu Fu
    Afshin Dowlati
    Investigational New Drugs, 2014, 32 : 362 - 368
12345